The role of PDGF-D in mesangioproliferative glomerulonephritis

Contributions to Nephrology

Volumn 157, Issue , 2007, Pages 153-158

  Floege, Jürgen ^a,b   Van Roeyen, Claudia ^a   Boor, Peter ^a   Ostendorf, Tammo ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOKINE; PDGFD PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL; CONFERENCE PAPER; DRUG ANTAGONISM; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; LYMPHOKINES; PLATELET-DERIVED GROWTH FACTOR;

EID: 34248997487     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102460     Document Type: Conference Paper

References (25)

1. Li X, Eriksson U: Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev 2003;14:91-98.
2. Changsirikulchai S, Hudkins KL, Goodpaster TA, et al: Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 2002;62:2043-2054.
3. Eitner F, Ostendorf T, Van Roeyen C, et al: Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J Am Soc Nephrol 2002;13:910-917.
4. Eitner F, Ostendorf T, Kretzler M, et al: PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J Am Soc Nephrol 2003;14:1145-1153.
5. Taneda S, Hudkins KL, Topouzis S, et al: Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol 2003;14:2544-2555.
6. Iida H, Seifert R, Alpers CE, et al: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991;88:6560-6564.
7. Seifert RA, Alpers CE, Bowen-Pope DF: Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int 1998;54:731-746.
8. Alpers CE, Seifert RA, Hudkins KL, et al: Developmental patterns of PDGF B-chain, PDGF-receptor, and alpha-actin expression in human glomerulogenesis. Kidney Int 1992;42:390-399.
9. Floege J, Hudkins KL, Davis CL, et al: Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J Am Soc Nephrol 1998;9:211-223.
10. Floege J, Hudkins KL, Seifert RA, et al: Localization of PDGF alpha-receptor in the developing and mature human kidney. Kidney Int 1997;51:1140-1150.
11. Leveen P, Pekny M, Gebre-Medhin S, et al: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994;8:1875-1887.
12. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994;8:1888-1896.
13. Silver BJ, Jaffer FE, Abboud HE: Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA 1989;86:1056-1060.
14. Floege J, Topley N, Hoppe J, et al: Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol 1991;86:334-341.
15. Floege J, Eng E, Young BA, et al: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-2962.
16. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92:2597-2601.
17. Floege J, Ostendorf T, Janssen U, et al: Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 1999;154:169-179.
18. Gilbert RE, Kelly DJ, McKay T, et al: PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 2001;59:1324-1332.
19. Nakamura H, Isaka Y, Tsujie M, et al: Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney Int 2001;59:2134-2145.
20. Ostendorf T, Kunter U, Grone HJ, et al: Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2001;12:909-918.
21. Ostendorf T, Van Roeyen CR, Peterson JD, et al: A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2003;14:2237-2247.
22. Hudkins KL, Gilbertson DG, Carling M, et al: Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 2004;15:286-298.
23. Johnson RJ, Iida H, Alpers CE, et al: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-858.
24. Ostendorf T, Rong S, Boor P, et al: Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:1054-1062.
25. Boor P, Konieczny A, Villa L, et al: PDGF-D inhibition by CR002 in late stages of experimental glomerulonephritis ameliorates tubulointerstitial fibrosis. Nephrol Dial Transplant 2007, doi: 10.1093/ndt/gfl691.